fda warning bpc 157 peptide unapproved status fda products bpc-157 tb-500 BPC-157 TB Without safety and efficacy data,
Description
Occasionally, a small lump or slight irritation can occur at a subcutaneous injection site, which is usually just the liquid sitting in the tissue before its fully absorbed
Book Chapters Holliday EB, Smith BD, Gross ND, Fuller CD, Rosenthal DI
Another issue is pain
Ipamorelin Selectivity Raun et al
No side effects and great shipping
[6] Phase I trials tested rectal administration of BPC-157 in healthy volunteers and found it safe and well-tolerated
